BRAINTREE, Mass. (AP) _ Haemonetics Corp. (HAE) on Tuesday reported fiscal third-quarter net income of $18.3 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Braintree, Massachusetts-based company said it had net income of 35 cents. Earnings, adjusted for non-recurring costs and amortization costs, were 63 cents per share.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 59 cents per share.
The provider blood management systems for health care providers and blood collectors posted revenue of $247.4 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $250.2 million.
Haemonetics expects full-year earnings in the range of $2.25 to $2.35 per share.
Haemonetics shares have decreased roughly 3 percent since the beginning of the year. The stock has risen 53 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HAE at https://www.zacks.com/ap/HAE